Catheter survival during long-term insulin therapy with an implanted programmable pump

被引:19
作者
Scavini, M
Galli, L
Reich, S
Eaton, RP
Charles, MA
Dunn, FL
Micossi, P
Torri, M
Petrella, G
Galimberti, G
Cristallo, M
Vai, S
Pozza, G
Olsen, C
Turner, D
Nolleman, C
LavinTompkins, J
Selam, JL
Haardt, MJ
Dorange, C
Jeandidier, N
Ortega, F
Boivin, S
Nathan, D
Larkin, M
McKitrick, C
Schwarz, S
Fisher, J
Kipnes, S
Walz, B
Vague, P
Reeves, ML
Goudner, M
Thomson, GP
Jaffiol, C
Renard, E
Lauton, D
JacquesApostol, D
Bringer, J
Tauber, JP
HanaireBroutin, H
ReesJones, R
Adolff, S
Bays, HA
Pfeifer, M
Clarke, D
Irsigler, K
Feinboch, C
Hutter, R
Mendel, H
机构
[1] STRATO INFUSAID, NORWOOD, MA USA
[2] UNIV NEW MEXICO, ALBUQUERQUE, NM 87131 USA
[3] UNIV CALIF IRVINE, DIABET RES PROGRAM, IRVINE, CA 92717 USA
[4] DUKE UNIV, MED CTR, DURHAM, NC USA
[5] HOP HOTEL DIEU, PARIS, FRANCE
[6] UNIV STRASBOURG, STRASBOURG, FRANCE
[7] MASSACHUSETTS GEN HOSP, BOSTON, MA 02114 USA
[8] SAN ANTONIO REG MED CTR, SAN ANTONIO, TX USA
[9] HOP ENFANTS LA TIMONE, MARSEILLE, FRANCE
[10] E RIDGE HOSP, CHATTANOOGA, TN USA
[11] HOP LAPEYRONIE, MONTPELLIER, FRANCE
[12] HOP RANGUEIL, TOULOUSE, FRANCE
[13] AURORA REG MED CTR, AURORA, CO USA
[14] HUMANA LEXINGTON, LEXINGTON, KY USA
[15] DIABET HLTH CTR, SALT LAKE CITY, UT USA
[16] VIENNA LAINZ HOSP, VIENNA, AUSTRIA
关键词
D O I
10.2337/diacare.20.4.610
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
OBJECTIVE - To survey catheter complications and to analyze catheter survival during long-term intraperitoneal and intravenous insulin therapy with an implanted programmable pump with a sideport. RESEARCH DESIGN AND METHODS - Catheter occlusions were documented by measuring dynamic catheter resistance. Catheter migrations or breaks were demonstrated by X ray. When flushing the catheter with buffer solution through the sideport failed to clear the occlusion, catheters were replaced or laparoscopy was performed for the excision of fibrous tissue growth. Broken or migrated catheters were replaced. RESULTS - Occlusions were the most common catheter complications, and the majority of them (79% intraperitoneal and 84% intravenous) were cleared by flushing the catheter. Survival at 3 years was significantly higher for intraperitoneal catheters compared with intravenous catheters (60% intraperitoneal and 22% intravenous). CONCLUSIONS - Nonsurgical management of catheter occlusions contributed to extend catheter lifetime. Intraperitoneal catheters have a lower morbidity and a higher survival than intravenous catheters.
引用
收藏
页码:610 / 613
页数:4
相关论文
共 14 条
[1]
FACTORS INVOLVED IN CATHETER OBSTRUCTION DURING LONG-TERM PERITONEAL INSULIN INFUSION [J].
BOUSQUETROUAUD, R ;
CASTEX, F ;
COSTALAT, G ;
BASTIDE, M ;
HEDON, B ;
BOUANANI, M ;
JOUVERT, S ;
MIROUZE, J .
DIABETES CARE, 1993, 16 (05) :801-805
[2]
FRENCH MULTICENTER EXPERIENCE OF IMPLANTABLE INSULIN PUMPS [J].
BROUSSOLLE, C ;
JEANDIDIER, N ;
HANAIREBROUTIN, H .
LANCET, 1994, 343 (8896) :514-515
[3]
Long-term therapy of IDDM with an implantable insulin pump [J].
Dunn, FL ;
Nathan, DM ;
Scavini, M ;
Selam, JL ;
Wingrove, TG ;
ReesJones, R ;
Krasnisky, L ;
Adolff, S ;
Clarke, D ;
Tomky, D ;
Ford, K ;
Dunn, F ;
LavinTompkins, J ;
Reeves, M ;
Thomson, G ;
Goodner, M ;
Pfeifer, M ;
White, D ;
Bourke, J ;
Larkin, M ;
McKitrick, C ;
Haggan, C ;
Fogel, H ;
Schwartz, S ;
Walz, B ;
Fischer, J ;
Charles, MA ;
Wucetich, K ;
Turner, D ;
Holleman, C ;
Olsen, C ;
Micossi, P ;
Cristallo, M ;
Pozza, G ;
Winkler, W ;
Sarmiento, M ;
Foote, F ;
Damme, L ;
Macedo, M .
DIABETES CARE, 1997, 20 (01) :59-63
[4]
FEASIBILITY OF INTRAPERITONEAL INSULIN THERAPY WITH PROGRAMMABLE IMPLANTABLE PUMPS IN IDDM - A MULTICENTER STUDY [J].
HANAIREBROUTIN, H ;
BROUSSOLLE, C ;
JEANDIDIER, N ;
RENARD, E ;
GUERCI, B ;
HAARDT, MJ ;
LASSMANNVAGUE, V ;
PINGET, M ;
TAUBER, JP ;
BRINGER, J ;
VAGUE, P ;
RACCAH, D ;
DROUIN, P ;
ZIEGLER, O ;
SELAM, JL ;
SLAMA, G ;
GILLY, F .
DIABETES CARE, 1995, 18 (03) :388-392
[5]
HEPP KD, 1988, LANCET, V2, P866
[6]
NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[7]
KNATTERUD G, 1991, RBM, V13, P160
[8]
MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163
[9]
LONG-TERM SAFETY AND EFFICACY OF PROGRAMMABLE IMPLANTABLE INSULIN DELIVERY SYSTEMS [J].
OLSEN, CL ;
LIU, G ;
IRAVANI, M ;
NGUYEN, S ;
KHOURDADJIAN, K ;
TURNER, DS ;
WAXMAN, K ;
SELAM, JL ;
CHARLES, MA .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1993, 16 (12) :847-854
[10]
PINGET M, 1995, INT J ARTIF ORGANS, V18, P322